The future of molecular diagnostics is looking particularly bright as international teams of researchers and entrepreneurs make profound headway in the development of disease-sensing instruments.
The molecular mechanisms that cause rare species of mushrooms to glow in the dark have baffled scientists for years. A new study set to finally uncover the mystery behind their bioluminescence revealed that it is in fact based on luciferin oxidation, the same chemical process used by fireflies.
Scientists have managed to completely eliminate the HIV virus in living mice using the revolutionary CRISPR/Cas9 gene-editing technology. They have demonstrated how it excises the viral DNA from the host animal and prevents further infection, providing hope that it could one day benefit humans.
Researchers at Harvard University developed an effective personalized cancer vaccine that seems to have prevented early tumour relapse in 12 skin cancer patients. The vaccine targeted 20 tumour-specific proteins unique to each of the patients enrolled, keeping all free of cancer over 2 years after the trial.
A group of US researchers proposed a cutting edge alternative for eliminating resilient bacteria in the form of a “CRISPR pill”. The drug can specifically target harmful bugs using a combination of bacteria-seeking viruses and a cocktail of probiotics, making it more potent than most antibiotics.
Researchers at the University of Leuven (KU Leuven) have discovered that stevia stimulates a protein that is essential for our perception of taste and is involved in the release of insulin after a meal. These results create new possibilities for the treatment of diabetes.
Canadian researchers discovered that components of maple syrup may boost the antimicrobial effects of antibiotics by as much as 90% when used in combination. This synergy could provide an effective solution for the alarming threat of multi-drug resistant bacteria.
US scientists discovered a surprising hidden function of mammalian lungs – they help produce blood. Their study on mice showed that more than half of all platelets in mice are produced by the lungs, a process long attributed to bone marrow.
The heated legal war over the ownership of the revolutionary CRISPR/Cas9 gene-editing technology has finally reached a verdict. The US Patent and Trademark Office (UPTO) concluded that evidence favored the Broad Institute of MIT and Harvard for most patents rather than UC Berkeley, the technology´s initial inventor.
While labs are facing growing amounts of data, solutions are opening up on the global scene to help them cope with it. The change is already here. And it might be better than we expected.